<page><title>Limb-girdle muscular dystrophy</title><url>https://medlineplus.gov/genetics/condition/limb-girdle-muscular-dystrophy</url><content>Limb-girdle muscular dystrophy
To use the sharing features on this page, please enable JavaScript.
Description
Limb-girdle muscular dystrophy is a term for a group of diseases that cause weakness and wasting of the muscles in the arms and legs. The muscles most affected are those closest to the body (proximal muscles), specifically the muscles of the shoulders, upper arms, pelvic area, and thighs.
The severity, age of onset, and features of limb-girdle muscle dystrophy vary among the many subtypes of this condition and may be inconsistent even within the same family. Signs and symptoms may first appear at any age and generally worsen with time, although in some cases they remain mild.
In the early stages of limb-girdle muscular dystrophy, affected individuals may have an unusual walking gait, such as waddling or walking on the balls of their feet, and may also have difficulty running. They may need to use their arms to press themselves up from a squatting position because of their weak thigh muscles. As the condition progresses, people with limb-girdle muscular dystrophy may eventually require wheelchair assistance.
Muscle wasting may cause changes in posture or in the appearance of the shoulder, back, and arm. In particular, weak shoulder muscles tend to make the shoulder blades (scapulae) "stick out" from the back, a sign known as scapular winging. Affected individuals may also have an abnormally curved lower back (
lordosis
) or a spine that curves to the side (
scoliosis
). Some develop joint stiffness (contractures) that can restrict movement in their hips, knees, ankles, or elbows. Overgrowth (hypertrophy) of the calf muscles occurs in some people with limb-girdle muscular dystrophy.
Weakening of the heart muscle (cardiomyopathy) occurs in some forms of limb-girdle muscular dystrophy. Some affected individuals experience mild to severe breathing problems related to the weakness of muscles needed for breathing. In some cases, the breathing problems are severe enough that affected individuals need to use a machine to help them breathe (mechanical ventilation).
Intelligence is generally unaffected in limb-girdle muscular dystrophy; however, developmental delay and intellectual disability have been reported in rare forms of the disorder.
Frequency
It is difficult to determine the prevalence of limb-girdle muscular dystrophy because its features vary and overlap with those of other muscle disorders. Prevalence estimates range from 1 in 14,500 to 1 in 123,000 individuals.
Causes
The various forms of limb-girdle muscular dystrophy are caused by mutations in many different genes. These genes provide instructions for making proteins that are involved in muscle maintenance and repair.
Some of the proteins produced from these genes assemble with other proteins into larger protein complexes. These complexes maintain the physical integrity of muscle tissue and allow the muscles to contract. Other proteins participate in cell signaling, cell membrane repair, or the removal of potentially toxic wastes from muscle cells.
Limb-girdle muscular dystrophy is classified on the basis of its inheritance pattern and genetic cause. Limb-girdle muscular dystrophy type 1 includes forms of the disorder that have an inheritance pattern called
autosomal dominant
. Limb-girdle muscular dystrophy type 2 includes forms of the disorder that have an inheritance pattern called
autosomal recessive
.
Calpainopathy, or limb-girdle muscular dystrophy type 2A, is caused by mutations in the
CAPN3
gene. Type 2A is the most common form of limb-girdle muscular dystrophy, accounting for about 30 percent of cases. Dysferlinopathy, also called limb-girdle muscular dystrophy type 2B, is caused by mutations in the
DYSF
gene.
Sarcoglycanopathies are forms of limb-girdle muscular dystrophy caused by mutations in the
SGCA
,
SGCB
,
SGCG
, and
SGCD
genes. These sarcoglycanopathies are known as limb-girdle muscular dystrophy types 2D, 2E, 2C, and 2F respectively.
A
TTN
gene mutation causes limb-girdle muscular dystrophy type 2J, which has been identified only in the Finnish population. Mutations in the
ANO5
gene cause limb-girdle muscular dystrophy type 2L. Mutations in several other genes cause forms of limb-girdle muscular dystrophy called dystroglycanopathies, including limb-girdle muscular dystrophy types 2I, 2K, 2M, and 2N.
Other rare forms of limb-girdle muscular dystrophy are caused by mutations in several other genes, some of which have not been identified. In addition, for certain forms that are classified by some researchers as limb-girdle muscular dystrophy, other researchers propose grouping them with different, related disorders, such as
myofibrillar myopathy
,
Emery-Dreifuss muscular dystrophy
,
rippling muscle disease
, or
Pompe disease
.
Learn more about the genes associated with Limb-girdle muscular dystrophy
ANO5
CAPN3
CAV3
COL6A1
COL6A2
COL6A3
CRPPA
DYSF
FKRP
FKTN
LAMA2
LMNA
MYOT
PLEC
POGLUT1
POMT1
POMT2
SGCA
SGCB
SGCD
SGCG
TTN
Additional Information from NCBI Gene:
DAG1
DNAJB6
GMPPB
HNRNPDL
POMGNT1
POMGNT2
TCAP
TNPO3
TRAPPC11
TRIM32
Inheritance
Limb-girdle muscular dystrophy can have different inheritance patterns.
Most forms of this condition are inherited in an
autosomal recessive pattern
, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.
Several rare forms of limb-girdle muscular dystrophy are inherited in an
autosomal dominant pattern
, which means one copy of the altered gene in each cell is sufficient to cause the disorder.
Other Names for This Condition
LGMD
Limb-girdle syndrome
Myopathic limb-girdle syndrome
Additional Information &amp; Resources
Genetic Testing Information
Genetic Testing Registry: Limb-girdle muscular dystrophy
Genetic and Rare Diseases Information Center
Limb-girdle muscular dystrophy
Patient Support and Advocacy Resources
National Organization for Rare Disorders (NORD)
Clinical Trials
ClinicalTrials.gov
Catalog of Genes and Diseases from OMIM
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 7; LGMDR7
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 6; LGMDR6
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 1; LGMDR1
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2; LGMDR2
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 5; LGMDR5
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 8; LGMDR8
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1; LGMDD1
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4; LGMDR4
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 3; LGMDR3
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12; LGMDR12
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 3; LGMDD3
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17; LGMDR17
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 21; LGMDR21
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9
Scientific Articles on PubMed
PubMed
References
Angelini C, Giaretta L, Marozzo R. An update on diagnostic options and
considerations in limb-girdle dystrophies. Expert Rev Neurother. 2018
Sep;18(9):693-703. doi: 10.1080/14737175.2018.1508997. Epub 2018 Aug 21.
Citation on PubMed
Chu ML, Moran E. The Limb-Girdle Muscular Dystrophies: Is Treatment on the
Horizon? Neurotherapeutics. 2018 Oct;15(4):849-862. doi:
10.1007/s13311-018-0648-x.
Citation on PubMed
or
Free article on PubMed Central
Khadilkar SV, Patel BA, Lalkaka JA. Making sense of the clinical spectrum of
limb girdle muscular dystrophies. Pract Neurol. 2018 Jun;18(3):201-210. doi:
10.1136/practneurol-2017-001799. Epub 2018 Feb 22.
Citation on PubMed
Liewluck T, Milone M. Untangling the complexity of limb-girdle muscular
dystrophies. Muscle Nerve. 2018 Aug;58(2):167-177. doi: 10.1002/mus.26077. Epub
2018 Feb 7.
Citation on PubMed
Liu W, Pajusalu S, Lake NJ, Zhou G, Ioannidis N, Mittal P, Johnson NE, Weihl
CC, Williams BA, Albrecht DE, Rufibach LE, Lek M. Estimating prevalence for
limb-girdle muscular dystrophy based on public sequencing databases. Genet Med.
2019 Nov;21(11):2512-2520. doi: 10.1038/s41436-019-0544-8. Epub 2019 May 20.
Citation on PubMed
Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, Jette N. A
Systematic Review and Meta-analysis on the Epidemiology of the Muscular
Dystrophies. Can J Neurol Sci. 2016 Jan;43(1):163-77. doi: 10.1017/cjn.2015.311.
Citation on PubMed
Mitsuhashi S, Kang PB. Update on the genetics of limb girdle muscular
dystrophy. Semin Pediatr Neurol. 2012 Dec;19(4):211-8. doi:
10.1016/j.spen.2012.09.008.
Citation on PubMed
Straub V, Murphy A, Udd B; LGMD workshop study group. 229th ENMC international
workshop: Limb girdle muscular dystrophies - Nomenclature and reformed
classification Naarden, the Netherlands, 17-19 March 2017. Neuromuscul Disord.
2018 Aug;28(8):702-710. doi: 10.1016/j.nmd.2018.05.007. Epub 2018 May 24. No
abstract available.
Citation on PubMed
Thompson R, Straub V. Limb-girdle muscular dystrophies - international
collaborations for translational research. Nat Rev Neurol. 2016
May;12(5):294-309. doi: 10.1038/nrneurol.2016.35. Epub 2016 Apr 1.
Citation on PubMed
Wicklund MP, Kissel JT. The limb-girdle muscular dystrophies. Neurol Clin.
2014 Aug;32(3):729-49, ix. doi: 10.1016/j.ncl.2014.04.005.
Citation on PubMed
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.
Official websites use .gov
A
.gov
website belongs to an official government
              organization in the United States.
Secure .gov websites use HTTPS
A
lock
(
Lock
Locked padlock icon
) or
https://
means youâ€™ve safely connected to
              the .gov website. Share sensitive information only on official,
              secure websites.</content></page>